Loading clinical trials...
Loading clinical trials...
This study will assess the progression of RP as seen on newer modalities including spectral-domain optical coherence (SD-OCT) and macular assessment integrity (MAIA) microperimetry to evaluate disease...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Johns Hopkins University
NCT01432847 · Retinal Disease, AMD, and more
NCT01866371 · Stargardts, Retinitis Pigmentosa, and more
NCT07548944 · Retinitis Pigmentosa (RP), Usher Syndrome, and more
NCT06789445 · Primary Photoreceptor Disease, Retinitis Pigmentosa (RP), and more
NCT06912633 · Retinitis Pigmentosa
Wilmer Eye Institute at Johns Hopkins University
Baltimore, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions